ECSP077228A - Proceso para la preparación de derivados de estrona y de estradiol sustituidos en la posición 2 - Google Patents
Proceso para la preparación de derivados de estrona y de estradiol sustituidos en la posición 2Info
- Publication number
- ECSP077228A ECSP077228A EC2007007228A ECSP077228A ECSP077228A EC SP077228 A ECSP077228 A EC SP077228A EC 2007007228 A EC2007007228 A EC 2007007228A EC SP077228 A ECSP077228 A EC SP077228A EC SP077228 A ECSP077228 A EC SP077228A
- Authority
- EC
- Ecuador
- Prior art keywords
- compound
- general formula
- preparation
- provides
- estradiol
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 title abstract 2
- 150000002159 estradiols Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 10
- 229960003399 estrone Drugs 0.000 abstract 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 abstract 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 238000005899 aromatization reaction Methods 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- VOXZDWNPVJITMN-WKUFJEKOSA-N estradiol group Chemical group [C@@H]12CCC(O)[C@@]1(C)CC[C@@H]1C3=C(CC[C@@H]21)C=C(O)C=C3 VOXZDWNPVJITMN-WKUFJEKOSA-N 0.000 abstract 1
- 230000001076 estrogenic effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención provee un proceso para la preparación de derivados de estrona y de estradiol sustituidos en la posición 2, el cual comprende i) la preparación de un compuesto de la fórmula general (II) por medio de reacción de un compuesto de la fórmula general (I), en una o más etapas, a un compuesto de la fórmula general II, en donde R1 es un grupo alquenilo, arilo o alquilo C1-C10; -Cl, -Br, -I, -F; -CN; -OH; o un grupo -OR2, -O(CO)R2 o -R2-OH, en donde R2 es un grupo alquilo o alquileno que tiene de 1 a 6 átomos de carbono; y el enlazamiento entre los átomos 9 y 10 es un enlace simple o doble; ii) la aromatización del compuesto de la fórmula general II a un compuesto de la fórmula general III, en donde R1 y R2 tienen los significados proporcionados anteriormente; y iii) opcionalmente, la reducción del compuesto de la fórmula general III a un compuesto de la fórmula general IV, en donde R1 y R2 tienen los significados proporcionados anteriormente. Además, la invención provee varios compuestos nuevos, que pueden ser compuestos intermediarios en el proceso antes mencionado, y procesos para preparar estos nuevos compuestos. La invención también provee 2-alcoxi-estrona, 2-alcoxi-estradiol o mezclas de los mismos, básicamente libres de otros intermediarios estrogénicos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04103742 | 2004-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP077228A true ECSP077228A (es) | 2007-03-29 |
Family
ID=34929415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2007007228A ECSP077228A (es) | 2004-08-04 | 2007-02-05 | Proceso para la preparación de derivados de estrona y de estradiol sustituidos en la posición 2 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7910756B2 (es) |
| EP (1) | EP1776378B1 (es) |
| JP (1) | JP5075626B2 (es) |
| KR (1) | KR20070040386A (es) |
| CN (1) | CN1993376A (es) |
| AR (1) | AR050195A1 (es) |
| AT (1) | ATE447580T1 (es) |
| AU (1) | AU2005268768B2 (es) |
| BR (1) | BRPI0514096A (es) |
| CA (1) | CA2573133C (es) |
| DE (1) | DE602005017500D1 (es) |
| EC (1) | ECSP077228A (es) |
| ES (1) | ES2334244T3 (es) |
| IL (1) | IL180381A0 (es) |
| MX (1) | MX2007001340A (es) |
| NO (1) | NO20070747L (es) |
| RU (1) | RU2007107914A (es) |
| TW (1) | TW200611909A (es) |
| WO (1) | WO2006013196A1 (es) |
| ZA (1) | ZA200700483B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ300376B6 (cs) | 2008-05-05 | 2009-05-06 | Prírodovedecká Fakulta Uk | Ligandy estrogenových receptoru alfa a beta, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují |
| WO2012020417A1 (en) | 2010-08-10 | 2012-02-16 | Reliance Life Sciences Pvt. Ltd. | Process for the preparation of estradiol and its derivatives |
| EP2742352B1 (en) * | 2011-08-12 | 2018-02-28 | Siemens Healthcare Diagnostics Inc. | Detection of sex steroids |
| CN104592339A (zh) * | 2014-12-30 | 2015-05-06 | 湖南新合新生物医药有限公司 | 雌甾-4,9-二烯-3,17-二酮的制备方法 |
| CN104497088B (zh) * | 2014-12-30 | 2016-08-24 | 湖南新合新生物医药有限公司 | 19-去甲-4-雄甾烯-3,17-二酮的制备方法 |
| ITUB20155260A1 (it) * | 2015-10-30 | 2017-04-30 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI 17?-idrossi-des-A-androst-9,10-en-5-one |
| CN108003210A (zh) * | 2018-01-24 | 2018-05-08 | 四川理工学院 | 一种雌甾-4,9-二烯-3,17-二酮的制备方法 |
| CN108997463B (zh) * | 2018-08-09 | 2021-05-14 | 四川理工学院 | 一种雌甾-4，9-二烯-3，17-二酮制备方法 |
| CN112409434B (zh) * | 2020-11-27 | 2021-10-26 | 厦门欧瑞捷生物科技有限公司 | 一种去氢孕酮的合成方法 |
| CN113861158B (zh) * | 2021-11-22 | 2023-02-10 | 湖南新合新生物医药有限公司 | 一种合成甲基双烯双酮关键中间体的方法 |
| CN114853802B (zh) * | 2022-03-22 | 2023-11-28 | 河北康泰药业有限公司 | 一种谷内酯衍生物及其制备方法、药物组合物和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2997488A (en) * | 1959-06-20 | 1961-08-22 | Organon | 2-methyl-19-nor-steroids |
| FR1468608A (fr) * | 1960-08-04 | 1967-02-10 | Upjohn Co | 2-alpha-fluoro stéroïdes de la série de la 19-norandrostène et leur procédé d'obtention |
| CH409944A (fr) | 1961-04-14 | 1966-03-31 | Roussel Uclaf | Procédé de préparation de dérivés de la 19-nor-testostérone |
| FR1368721A (fr) * | 1961-04-14 | 1964-08-07 | Roussel Uclaf | Dérivés de la 19-nor testostérone et procédé de préparation |
| US3519714A (en) * | 1966-03-15 | 1970-07-07 | Herchel Smith | Synthesis of gona-1,3,5(10)-trienes |
| US4400524A (en) * | 1981-07-28 | 1983-08-23 | The Upjohn Company | Grignard reagents prepared from 5-halopentan-2-one propylene ketals |
| DE3208432A1 (de) | 1982-03-09 | 1983-09-15 | The Upjohn Co., 49001 Kalamazoo, Mich. | Verfahren zur herstellung von 19-norandrostendion, zwischenprodukt des 19-norandrostendions und verfahren zu seiner herstellung |
| US5504074A (en) * | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US5521168A (en) * | 1994-10-13 | 1996-05-28 | Alcon Laboratories, Inc. | Estrogen metabolites for lowering intraocular pressure |
| US5998639A (en) * | 1995-11-06 | 1999-12-07 | Akzo Nobel, N.V. | Sulfatation of estrogen mixtures |
| IL119649A (en) | 1995-11-30 | 2002-03-10 | Akzo Nobel Nv | Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians |
| US6051726A (en) * | 1997-03-13 | 2000-04-18 | Pharm-Eco Laboratories, Inc. | Synthesis of 2-alkoxyestradiols |
| US7087592B1 (en) * | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| AU7572600A (en) | 1999-08-23 | 2001-03-19 | Entremed, Inc | Methods of obtaining 2-methoxyestradiol of high purity |
| EP1343803A2 (en) | 2000-11-27 | 2003-09-17 | EntreMed, Inc. | 2-substituted estrogens as antiangiogenic agents |
-
2005
- 2005-07-14 TW TW094123942A patent/TW200611909A/zh unknown
- 2005-08-01 JP JP2007524335A patent/JP5075626B2/ja not_active Expired - Fee Related
- 2005-08-01 US US11/659,147 patent/US7910756B2/en not_active Expired - Fee Related
- 2005-08-01 EP EP05767940A patent/EP1776378B1/en not_active Expired - Lifetime
- 2005-08-01 AT AT05767940T patent/ATE447580T1/de not_active IP Right Cessation
- 2005-08-01 WO PCT/EP2005/053732 patent/WO2006013196A1/en not_active Ceased
- 2005-08-01 KR KR1020077002976A patent/KR20070040386A/ko not_active Ceased
- 2005-08-01 AU AU2005268768A patent/AU2005268768B2/en not_active Ceased
- 2005-08-01 ES ES05767940T patent/ES2334244T3/es not_active Expired - Lifetime
- 2005-08-01 CA CA2573133A patent/CA2573133C/en not_active Expired - Fee Related
- 2005-08-01 DE DE602005017500T patent/DE602005017500D1/de not_active Expired - Lifetime
- 2005-08-01 CN CNA2005800261640A patent/CN1993376A/zh active Pending
- 2005-08-01 MX MX2007001340A patent/MX2007001340A/es active IP Right Grant
- 2005-08-01 RU RU2007107914/04A patent/RU2007107914A/ru not_active Application Discontinuation
- 2005-08-01 BR BRPI0514096-0A patent/BRPI0514096A/pt not_active IP Right Cessation
- 2005-08-04 AR ARP050103233A patent/AR050195A1/es unknown
-
2006
- 2006-12-27 IL IL180381A patent/IL180381A0/en unknown
-
2007
- 2007-01-16 ZA ZA200700483A patent/ZA200700483B/xx unknown
- 2007-02-05 EC EC2007007228A patent/ECSP077228A/es unknown
- 2007-02-08 NO NO20070747A patent/NO20070747L/no not_active Application Discontinuation
-
2011
- 2011-02-22 US US13/031,975 patent/US20110152544A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2573133A1 (en) | 2006-02-09 |
| ZA200700483B (en) | 2008-09-25 |
| MX2007001340A (es) | 2007-03-27 |
| DE602005017500D1 (de) | 2009-12-17 |
| JP2008509109A (ja) | 2008-03-27 |
| AU2005268768B2 (en) | 2011-10-13 |
| RU2007107914A (ru) | 2008-09-10 |
| US20090012319A1 (en) | 2009-01-08 |
| NO20070747L (no) | 2007-04-23 |
| IL180381A0 (en) | 2007-06-03 |
| BRPI0514096A (pt) | 2008-05-27 |
| US7910756B2 (en) | 2011-03-22 |
| CN1993376A (zh) | 2007-07-04 |
| CA2573133C (en) | 2012-07-10 |
| WO2006013196A1 (en) | 2006-02-09 |
| EP1776378B1 (en) | 2009-11-04 |
| TW200611909A (en) | 2006-04-16 |
| US20110152544A1 (en) | 2011-06-23 |
| ATE447580T1 (de) | 2009-11-15 |
| KR20070040386A (ko) | 2007-04-16 |
| EP1776378A1 (en) | 2007-04-25 |
| JP5075626B2 (ja) | 2012-11-21 |
| ES2334244T3 (es) | 2010-03-08 |
| AU2005268768A1 (en) | 2006-02-09 |
| AR050195A1 (es) | 2006-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077228A (es) | Proceso para la preparación de derivados de estrona y de estradiol sustituidos en la posición 2 | |
| AR070479A1 (es) | Derivado heterociclico fusionado y su uso | |
| UY28878A1 (es) | Compuestos de aril-o heteroarilamida ortosustituidos y composiciones | |
| CO5580815A2 (es) | Derivados de adamantana, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
| AR066970A1 (es) | Derivado de 17 beta-ciano-18a-homo-19-nor-androst-4- eno, su uso y medicamento que lo contiene | |
| ECSP066968A (es) | Compuestos de metil-aril o heteroaril-amida sustituida | |
| PE20061298A1 (es) | Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c | |
| AR043508A1 (es) | 1-amino 1-h-imidazoquinolinas y su uso como inmunomoduladores | |
| UY29702A1 (es) | Inhibidores macrocíclicos del virus de hepatitis c | |
| AR061369A1 (es) | Derivados de pirimidina y composiciones farmaceuticas que los comprenden | |
| AR067770A1 (es) | Derivados de tiazol y ditiazol para el tratamiento de diabetes | |
| PE20060590A1 (es) | COMPUESTOS ESTEROIDALES 15ß-SUSTITUIDOS CON ACTIVIDAD SELECTIVA DEL RECEPTOR DE ESTROGENOS | |
| PE20061447A1 (es) | Tigeciclina y metodos para preparar 9-aminominociclina | |
| ES2479718T3 (es) | Nuevos derivados de tetrahidroquinolina | |
| BRPI0912171A8 (pt) | Composto ativador de receptor de glicocorticoide, e, composição | |
| AR054583A1 (es) | Pantoprazol isotopicamente sustituido | |
| AR074413A1 (es) | Derivados de 2-morfolino-3-amido-piridina | |
| CU23822A3 (es) | Derivados de sulfonil-quinolina | |
| AR046768A1 (es) | Derivados de piridin-tetrazol, metodos de obtencion y composiciones farmaceuticas | |
| AR047810A1 (es) | Proceso quimico | |
| UY28911A1 (es) | Profármacos de esteroides con acción androgénica | |
| PE20242204A1 (es) | Compuestos de carbolina y uso de los mismos | |
| EP1309598A4 (en) | FLUORESCENT CONNECTIONS | |
| AR062676A1 (es) | Procedimiento mejorado para preparar compuestos de pirrolidina 1,3-disustituidas | |
| AR064457A1 (es) | Derivados de 7-[(8-aza-biciclo[3,2,1]oct-3-il)-oxi]-3-heteroaril-2-il-cromen-2-ona una composicion farmaceutica que los comprende y su uso para la elaboracion de un medicamento para el tratamiento de una enfermedad mediada por la ssri |